Oura, the Finnish firm responsible for one of the most well-known health-tracking smart rings, is about to list on the US stock market. This appears to be a defining moment for a brand that has attracted a burgeoning, devout following by focusing on recovery, sleep and daily preparedness rather than superficial fitness stats. With wearable technology extending well beyond the physical confines of the wristband, Oura’s willingness to go public is indicative of the increasing optimism for its product, and for relentless, keen health tracking.
The category of smart rings has grown much recently. Rings work as a more discreet option than bulky smart watches to capture data on sleep stages HRV body temperature and activity. Oura has targeted the higher end of the market with a range of rings designed with Science so that consumers obtain tons of longitudinal data rather than short-term step numbers.
The rings have been targeted at groups running from competitive athletes to average consumers exploring improved insights into their own recovery. This consistent demand has enabled the company to develop the subscriptionbased level of recurring revenue and brand power that are prerequisites for a public offering. A US listing would provide Oura with a louder voice in the capital markets and increase its profile among American consumers and institutions.
The US continues to be the largest market for consumer health tech, and being a listed business frequently offers more credibility with retailers, insurers and prospective partners. It also subjects the business to heightened scrutiny and demands on transparent financial reporting and ongoing balance sheet performance. For a business that has operated relatively autonomously until now, this is a step that will present both fresh challenges and opportunities.
Really, the timing is indicative of a larger movement towards digital health. As one example, consumers are showing a desire for solutions that provide assistance with bedtime, stress, and resiliencewhich is a trend better served by a product that emphasizes recoveriescore and tailored advice. The feedback from users suggesting the ring has altered how they think about everyday rest and energy levels. Sure such habitual usage drives sticky products, but sticky products underpin the business models of many wearable devices. The battle in space has not cooled down. More sizable tech companies have experimented with building out or running their own ring schemes, and many smaller innovators are hot on its heels.
Oura’s head start and repository of information may be a boon, but they will need to continue pouring resources into sensor precision, battery longevity, and software intel to keep up. Coming public could allow for that growth to be financed while providing the firm with a more tangible currency for acquisitions and hiring. The market for a health-tracking product is still evolving. Growing regulatory concerns about consumer-grade devices always poke around, as do inquiries about the privacy, security and validity of the data they generate. Oura continuously asserts that their ring is a wellness device and not a medical one, a critical distinction for its positioning and for their regulatory standing. As Oura prepares to go public, how they address this boundary and handle their user data will come under much scrutiny.
